| |
| Issue |
Title |
| |
| Vol 65, No 7 (2025) |
Pulmonary Embolism: Current Challenges and Future Directions |
Abstract
|
|
I. A. Merkulova, N. S. Germanov, Z. B. Bashankaeva, I. S. Yavelov, D. V. Pevzner, S. A. Boytsov |
| |
| Vol 65, No 5 (2025) |
Aortic Valve Stenosis and Acute Coronary Syndrome. Obvious Answers to Non-Obvious Questions |
Abstract
|
|
O. L. Barbarash, V. V. kashtalap |
| |
| Vol 65, No 5 (2025) |
Echocardiography in the Diagnosis of Pulmonary Hypertension: From Basic to Advanced |
Abstract
|
|
E. G. Malev, K. N. Malikov, N. S. Goncharova, M. A. Simakova, E. V. Karelkina, V. A. Ryabkov, O. M. Moiseeva |
| |
| Vol 65, No 5 (2025) |
Adherence to Treatment of Arterial Hypertension, the Place of Fixed-Dose Combinations |
Abstract
|
|
E. V. Akatova, M. A. Shikina |
| |
| Vol 65, No 1 (2025) |
Remodeling of the External Respiratory System in Chronic Heart Failure - a Factor of Pathogenesis and a Therapeutic Target |
Abstract
PDF (Rus)
|
|
Yu. L. Begrambekova |
| |
| Vol 65, No 1 (2025) |
Specific Therapy Strategy Choice for Patients With Pulmonary Arterial Hypertension and Inoperable Chronic Thromboembolic Pulmonary Hypertension: Switch or Escalate |
Abstract
PDF (Rus)
|
|
I. N. Lyapina, Z. S. Valieva, T. V. Martynyuk |
| |
| Vol 64, No 12 (2024) |
Chronic Thromboembolic Pulmonary Hypertension Drug Treatment |
Abstract
PDF (Rus)
|
|
S. N. Ivanov, A. M. Chernyavsky, A. G. Edemsky, O. Ya. Vasiltseva |
| |
| Vol 64, No 12 (2024) |
The Influence of Antithrombotic Therapy on the Risk Factors for Cardiovascular Complications in Patients With Coronary Artery Disease And Diabetes Mellitus. Emphasis on Hypercoagulation |
Abstract
PDF (Rus)
|
|
I. V. Zotova, A. O. Cherkasov |
| |
| Vol 64, No 11 (2024) |
Chronic Heart Failure: Focus on Differences Between Men and Women |
Abstract
PDF (Rus)
|
|
M. G. Glezer |
| |
| Vol 64, No 11 (2024) |
The Role of the Left Atrium in the Pathogenesis of Heart Failure With Preserved Ejection Fraction |
Abstract
PDF (Rus)
|
|
A. G. Ovchinnikov, A. V. Potekhina, A. Yu. Filatova, O. N. Svirida, M. Kh. Shogenova, M. S. Sobolevskaya, F. T. Ageev |
| |
| Vol 64, No 10 (2024) |
Management Strategy for Patients With Idiopathic Recurrent Pericarditis. Position Statement of the Experts of the Russian Society оf Cardiology and Eurasian Association of Therapists |
Abstract
PDF (Rus)
PDF (Eng)
|
|
G. P. Arutyunov, O. L. Barbarash, N. N. Vezikova, A. S. Galyavich, I. V. Zhirov, S. K. Zyryanov, N. A. Koziolova, O. M. Moiseeva, Ya. A. Orlova, M. M. Petrova, N. G. Poteshkina, E. I. Tarlovskaya, S. N. Tereshchenko, A. I. Chesnikova |
| |
| Vol 64, No 8 (2024) |
Rationale for Increasing Doses of Statins in Everyday Clinical Practice |
Abstract
PDF (Rus)
|
|
A. V. Susekov |
| |
| Vol 64, No 7 (2024) |
The effect of sodium-glucose cotransporter type 2 inhibitors on left ventricular diastolic function: current status and prospects |
Abstract
PDF (Rus)
|
|
E. V. Borisova, A. V. Barsukov, S. A. Glebova, A. V. Airapetyan |
| |
| Vol 64, No 6 (2024) |
Cardiomyopathies Caused by Pathogenic Variants in the DMD Gene |
Abstract
PDF (Rus)
|
|
S. E. Nagieva, A. V. Lavrov, S. A. Smirnikhina |
| |
| Vol 64, No 5 (2024) |
Heparin-Induced Thrombocytopenia |
Abstract
PDF (Rus)
|
|
A. B. Sugraliyev |
| |
| Vol 64, No 4 (2024) |
Features of the Course of Arterial Hypertension in the Era of the COVID-19 Pandemic: Common Pathogenetic Links Between Hypertension and SARS-CoV-2 |
Abstract
PDF (Rus)
|
|
S. A. Berns, M. S. Leontyeva, E. V. Tavlueva, V. S. Bashnyak, O. M. Drapkina |
| |
| Vol 64, No 4 (2024) |
Changing Concepts About Optimal Target Blood Pressure and the Therapeutic Advantages of Azilsartan for Achieving it |
Abstract
PDF (Rus)
|
|
S. R. Gilarevsky |
| |
| Vol 64, No 3 (2024) |
Stress-Echocardiography in Low-risk Acute Coronary Syndrome Without Persistent ST-segment Elevation Diagnostic Algorithm |
Abstract
PDF (Rus)
|
|
E. E. Abramenko, T. R. Ryabova, V. V. Ryabov, A. A. Boshchenko, R. S. Karpov |
| |
| Vol 64, No 3 (2024) |
Morphofunctional Analysis of the Role of Epicardial Adipose Tissue in the Formation of the Obesity Paradox in Chronic Heart Failure |
Abstract
PDF (Rus)
|
|
V. E. Milyukov, V. A. Bryukhanov, C. C. Nguyen |
| |
| Vol 63, No 11 (2023) |
Efficacy and Organoprotection of Triple Combinations in the Treatment of Arterial Hypertension |
Abstract
PDF (Rus)
|
|
E. V. Serdechnaya |
| |
| Vol 63, No 11 (2023) |
The Effects of Therapy for Iron Deficiency in Patients With Different Etiologies of Heart Failure and Concomitant Diseases |
Abstract
PDF (Rus)
|
|
T. M. Uskach, S. N. Tereschenko |
| |
| Vol 63, No 9 (2023) |
Features of the Diagnosis of Pulmonary Hypertension in Outpatient Practice |
Abstract
PDF (Rus)
|
|
K. A. Moseichuk, E. V. Filippov |
| |
| Vol 63, No 7 (2023) |
Iron deficiency in cardiac surgery patients and the possibility of its correction at the preoperative stage |
Abstract
PDF (Rus)
|
|
A. A. Garganeeva, O. V. Tukish, E. A. Kuzheleva, V. A. Fediunina, B. N. Kozlov |
| |
| Vol 63, No 6 (2023) |
What is “normal left ventricular ejection fraction” and its relationship with the pathogenesis and effectiveness of the treatment of heart failure |
Abstract
PDF (Rus)
|
|
F. T. Ageev, A. G. Ovchinnikov, S. F. Ageeva, V. Yu. Mareev |
| |
| Vol 63, No 6 (2023) |
Review of international and European registers on infective endocarditis |
Abstract
PDF (Rus)
|
|
K. P. Haralampova, N. A. Cherkasova, S. A. Rachina, S. M. Nasruloeva |
| |
| Vol 63, No 5 (2023) |
Soluble guanylate cyclase: restoration of the NO–sGC–cGMP signaling pathway activity. A new opportunity in the treatment of heart failure |
Abstract
PDF (Rus)
|
|
Yu. N. Belenkov, M. V. Kozhevnikova |
| |
| Vol 63, No 3 (2023) |
Pharmacotherapy of heart failure with reduced ejection fraction: heart failure basic therapy and an episode of decompensation |
Abstract
PDF (Rus)
|
|
Zh. D. Kobalava, I. S. Nazarov |
| |
| Vol 63, No 3 (2023) |
State of the art mathematical methods of the coronary blood flow modelling: background and clinical value |
Abstract
PDF (Rus)
|
|
A. T. Suyundukova, V. P. Demkin, A. V. Mochula, M. O. Gulya, A. N. Maltseva, K. V. Zavadovsky |
| |
| Vol 63, No 2 (2023) |
Left bundle branch block – dilated cardiomyopathy – heart failure: common links in the closed pathogenetic chain |
Abstract
PDF (Rus)
|
|
E. M. Rimskaya, N. A. Mironova, S. F. Sokolov, S. P. Golitsyn |
| |
| Vol 63, No 2 (2023) |
Lipid-lowering Eeficacy and Safety of High Doses of Atorvastatin and Rosuvastatin |
Abstract
PDF (Rus)
|
|
A. V. Susekov |
| |
| Vol 63, No 1 (2023) |
The Revival of the “Ischemic” Approach in the Assessment of Ischemic Heart Disease: Analysis of Major World Research |
Abstract
PDF (Rus)
|
|
A. A. Ansheles |
| |
| Vol 62, No 11 (2022) |
Cardiac contractility modulation in heart failure with reduced ejection fraction treatment |
Abstract
PDF (Rus)
|
|
I. A. Chugunov, Yu. V. Mareev, M. Fudim, N. A. Mironova, V. Yu. Mareev, R. V. Davtyan |
| |
| Vol 62, No 10 (2022) |
Anatomical and Functional Approaches in the Assessment of Ischemia in Ischemic Heart Disease: Analysis of Major World Research |
Abstract
PDF (Rus)
|
|
A. A. Ansheles |
| |
| Vol 62, No 7 (2022) |
Testosterone and congestive heart failure |
Abstract
PDF (Rus)
|
|
T. N. Enina, V. A. Kuznetsov, A. M. Soldatova |
| |
| Vol 62, No 7 (2022) |
Functional heterogeneity of the von Willebrand factor: pathogenetic significance and practical aspects of use in cardiology |
Abstract
PDF (Rus)
|
|
I. V. Alekseeva, S. A. Urazgildeeva |
| |
| Vol 62, No 7 (2022) |
Treatment of patients with heart failure and preserved ejection fraction: reliance on clinical phenotypes |
Abstract
PDF (Rus)
|
|
F. T. Ageev, A. G. Ovchinnikov |
| |
| Vol 62, No 6 (2022) |
Pharmacotherapy optimization opportunities using fixed combinations in patients with high cardiovascular risk |
Abstract
PDF (Rus)
|
|
S. V. Povetkin, A. A. Kornilov |
| |
| Vol 62, No 6 (2022) |
Serum uric acid and the risk of ventricular arrhythmias: a systematic review |
Abstract
PDF (Eng)
|
|
Ivana Purnama Dewi, Kresna Nugraha Setia Putra, Kristin Purnama Dewi, Louisa Fadjri Kusuma Wardhani, Rerdin Julario, Budi Baktijasa Dharmadjati |
| |
| Vol 62, No 6 (2022) |
Inclisiran – a new era in lipid-lowering therapy |
Abstract
PDF (Rus)
|
|
M. I. Voevoda, V. S. Gurevich, M. V. Ezhov, I. V. Sergienko |
| |
| Vol 62, No 4 (2022) |
The role of platelet glycoprotein IIb / IIIa inhibitors in current treatment of acute coronary syndrome |
Abstract
PDF (Rus)
|
|
T. S. Sukhinina, D. V. Pevzner, A. V. Mazurov, T. N. Vlasik, N. G. Solovieva, N. S. Kostritca, R. M. Shakhnovich, I. S. Yavelov |
| |
| Vol 62, No 3 (2022) |
Frailty syndrome as an independent predictor of adverse prognosis in patients with chronic heart failure |
Abstract
PDF (Rus)
|
|
K. E. Krivoshapova, E. A. Vegner, Olga L. Barbarash |
| |
| Vol 62, No 3 (2022) |
Pathophysiological basis and diagnosis of the cardiovascular system damage caused by coronavirus infection |
Abstract
PDF (Rus)
|
|
E. K. Serezhina, A. G. Obrezan |
| |
| Vol 62, No 3 (2022) |
The role of thrombin in the pathogenesis of atherosclerosis and its complications |
Abstract
PDF (Rus)
|
|
O. A. Dukhin, A. I. Kalinsaya, A. V. Shpektor, E. Yu. Vasilieva |
| |
| Vol 62, No 3 (2022) |
Modern issues of improving the prognosis in patients with atrial fibrillation after ischemic stroke |
Abstract
PDF (Rus)
|
|
O. D. Ostroumova, T. M. Ostroumova, A. V. Arablinsky, V. N. Butorova, A. I. Kochetkova |
| |
| Vol 62, No 1 (2022) |
Thiazide and thiazide-like diuretics: how to make the right choice? |
Abstract
PDF (Rus)
|
|
O. D. Ostroumova, O. A. Polyakova, A. I. Listratova, N. A. Logunova, T. V. Gorohova |
| |
| Vol 62, No 1 (2022) |
Atrial fibrillation and cognitive impairment: features of the relationship, developmental and prevention mechanisms |
Abstract
PDF (Rus)
|
|
A. Ya. Kovaleva, V. L. Lukinov, G. I. Lifshits |
| |
| Vol 61, No 12 (2021) |
Decompensated heart failure with reduced ejection fraction: overcoming barriers to improve prognosis in the “vulnerable” period after discharge |
Abstract
PDF (Rus)
|
|
S. V. Villevalde, A. E. Soloveva |
| |
| Vol 61, No 12 (2021) |
Management of patients with atrial fibrillation and minor bleeding during therapy with direct oral anti-coagulants |
Abstract
PDF (Rus)
|
|
Yu. N. Belenkov, L. V. Popova, S. I. Ilgisonis |
| |
| Vol 61, No 12 (2021) |
History of development of ventricular arrhythmias diagnostics |
Abstract
PDF (Rus)
|
|
I. A. Taymasova, M. V. Yashkov, E. V. Dedukh, E. A. Artyukhina, A. Sh. Revishvili |
| |
| Vol 61, No 12 (2021) |
Patterns of immunological reactions in the pathogenesis of chronic heart failure: review |
Abstract
PDF (Rus)
|
|
E. A. Kuzheleva, V. A. Fedyunina, A. A. Garganeeva |
| |
| Vol 61, No 11 (2021) |
Features of pulmonary thromboembolism in women |
Abstract
PDF (Rus)
|
|
O. Ya. Vasiltseva, K. N. Vitt, A. M. Cherniavsky |
| |
| Vol 61, No 11 (2021) |
Personalized medicine in non-communicable diseases: latest advances and future prospects |
Abstract
PDF (Rus)
|
|
O. M. Drapkina, A. A. Ivanova |
| |
| Vol 61, No 10 (2021) |
Possibilities and limitations of the use of beta-blockers in patients with cardiovascular disease and chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
|
N. A. Karoli, A. P. Rebrov |
| |
| Vol 61, No 10 (2021) |
Features of anticoagulant therapy of atrial fibrillation in combination with impaired renal function |
Abstract
PDF (Rus)
|
|
T. N. Novikova |
| |
| Vol 61, No 8 (2021) |
Remote monitoring of patients with heart failure in real clinical practice |
Abstract
PDF (Rus)
|
|
S. N. Nasonova, A. E. Lapteva, I. V. Zhirov, S. N. Tereshchenko, S. A. Boytsov |
| |
| Vol 61, No 8 (2021) |
Significance of the echocardiographic evaluation of left atrial myocardial strain for early diagnosis of heart failure with preserved ejection fraction |
Abstract
PDF (Rus)
|
|
E. K. Serezhina, A. G. Obrezan |
| |
| Vol 61, No 7 (2021) |
What do we Mean by “Ideal” Blood Pressure Control? |
Abstract
PDF (Rus)
|
|
O. D. Ostroumova, A. I. Kochetkov, N. A. Arablincky, N. A. Shatalova, R. R. Romanovsky, A. A. Kirichenko |
| |
| Vol 61, No 7 (2021) |
Morphological and Molecular-Biological Changes in the Coronary Arteries after Stenting |
Abstract
PDF (Rus)
|
|
S. S. Todorov, V. J. Deribas, A. S. Kazmin, S. S. Todorov (jr.) |
| |
| Vol 61, No 7 (2021) |
Echocardiographic Diagnostics of Heart Tumors |
Abstract
PDF (Rus)
|
|
T. M. Domnitskaya, Yu. F. Sakhno, V. P. Sedov, N. M. Savina |
| |
| Vol 61, No 6 (2021) |
Possibilities of Magnetic Resonance Tomography in Diagnosis of Pulmonary Arterial Hypertension |
Abstract
PDF (Rus)
|
|
A. M. Shariya, T. V. Martynyuk, S. K. Ternovoy, M. A. Shariya |
| |
| Vol 61, No 6 (2021) |
Cardiovascular Risks Associated with the use of Performance-Enhancing Stimulants |
Abstract
PDF (Rus)
|
|
L. A. Balykova, L. M. Makarov, S. A. Ivyanskiy, K. A. Varlashina |
| |
| Vol 61, No 6 (2021) |
Omega-3 Polyunsaturated Fatty Acids in Patients with Hypertriglyceridemias and Atherosclerosis |
Abstract
PDF (Rus)
|
|
A. V. Susekov |
| |
| Vol 61, No 6 (2021) |
Atrial fibrillation in old age: risk management and features of the use of direct oral anticoagulants |
Abstract
PDF (Rus)
|
|
S. G. Kanorskii |
| |
| Vol 61, No 5 (2021) |
Forensic expert evaluation problems of early and late complications of interventional methods of treating coronary heart disease (systematic literature review) |
Abstract
PDF (Rus)
|
|
I. A. Kolomoets, S. S. Todorov, R. V. Sidorov, S. S. Bachurin, D. P. Berezovskii |
| |
| Vol 61, No 4 (2021) |
Cardiac Involvement in COVID-19 |
Abstract
PDF (Rus)
|
|
A. B. Sugraliyev |
| |
| Vol 61, No 3 (2021) |
The role of selenium in cardiology |
Abstract
PDF (Rus)
|
|
T. A. Kuropatkina, N. A. Medvedeva, O. S. Medvedev |
| |
| Vol 61, No 3 (2021) |
Features of Antithrombotic Therapy in Patients with Multifocal Arterial Disease |
Abstract
PDF (Rus)
|
|
V. G. Grachev, S. S. Vedenskaya, O. G. Smolenskaya |
| |
| Vol 61, No 3 (2021) |
Analysis of healthcare for patients with cardiovascular diseases in Russian Federation in comparison with the practice of Europe and USA |
Abstract
PDF (Rus)
|
|
E. A. Medvedeva, N. E. Zvartau, S. V. Villevalde, A. N. Yakovlev, A. E. Solovieva, A. A. Fedorenko, V. A. Karlina, V. V. Zaitsev, G. V. Endubaeva, S. A. Panarina, A. M. Erastov |
| |
| Vol 61, No 2 (2021) |
Atrial Fibrillation and Mortality: Prognostic Factors and Direction of Prevention |
Abstract
PDF (Rus)
|
|
A. V. Ardashev, Yu. N. Belenkov, M. Ch. Matsiukevich, V. A. Snezhitskiy |
| |
| Vol 61, No 2 (2021) |
The no-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction due to Massive Coronary Thrombosis. Pathogenesis and Predictors of no-Reflow |
Abstract
PDF (Rus)
|
|
A. S. Zhuravlev, A. V. Azarov, S. P. Semitko, D. G. Ioseliani |
| |
| Vol 61, No 1 (2021) |
Infective Endocarditis with Unknown Etiology: Possibilities of Conquering and Role of Microbiologistics |
Abstract
PDF (Rus)
|
|
E. O. Kotova, E. A. Domonova, Zh. D. Kobalava, O. Y. Shipulina, Y. L. Karaulova, A. S. Pisaryuk |
| |
| Vol 61, No 1 (2021) |
Atherosclerotic Cardiovascular Diseases and Type 2 Diabetes Mellitus – new Developments in the Treatment |
Abstract
PDF (Rus)
|
|
V. Y. Kalashnikov, M. S. Michurova |
| |
| Vol 61, No 1 (2021) |
Classification of stages of severe aortic stenosis based on the prevalence of extravalvular heart damage |
Abstract
PDF (Rus)
|
|
M. N. Alekhin |
| |
| Vol 60, No 12 (2020) |
Echocardiography in the Assessment of Postsystolic Shortening of the Left Ventricle Myocardium of the Heart |
Abstract
PDF (Rus)
|
|
M. N. Alekhin, A. I. Stepanova |
| |
| Vol 60, No 12 (2020) |
Detection of peripheral artery disease in patients with ischemic heart disease. A quick guide for medical practitioners |
Abstract
PDF (Rus)
|
|
D. P. Dundua, I. D. Strazhesko |
| |
| Vol 60, No 12 (2020) |
Asymptomatic Hyperuricemia: Treatment Approaches According to the Risk of Cardiovascular and Renal Events |
Abstract
PDF (Rus)
|
|
Zh. D. Kobalava, E. A. Troitskaya |
| |
| Vol 60, No 12 (2020) |
Antibiotic prophylaxis for infective endocarditis: current approaches |
Abstract
PDF (Rus)
|
|
G. G. Taradin, N. T. Vatutin, G. A. Ignatenko, E. Ju. Ponomareva, Bernard David Prendergast |
| |
| Vol 60, No 12 (2020) |
The new Epoch of Antithrombotic Therapy in the Long-Term Prevention of a non-Cardioembolic Stroke |
Abstract
PDF (Rus)
|
|
A. V. Fonyakin, L. A. Geraskina |
| |
| Vol 60, No 11 (2020) |
Circulating Neuregulin-1 and Chronic Heart Failure with Preserved Ejection |
Abstract
PDF (Rus)
|
|
A. A. Shchendrigina, K. A. Zhbanov, E. V. Privalova, A. O. Iusupova, A. H. Bytdaeva, Yu. A. Danilogorskaya, E. A. Zheleznykh, A. Yu. Suvorov, V, Yu. Zektser, M. G. Mnatsakanyan, O. V. Lyapidevskaya, N. V. Khabarova, Yu. I. Naymann, Yu. N. Belenkov, E. S. Starostina |
| |
| Vol 60, No 11 (2020) |
The Role of Neprilysin Inhibitors in the Treatment of Heart Failure with Preserved Ejection Fraction |
Abstract
PDF (Rus)
|
|
A. G. Ovchinnikov, A. D. Gvozdeva, Z. N. Blankova, A. A. Borisov, F. T. Ageev |
| |
| Vol 60, No 11 (2020) |
New Possibilities to Reduce the Residual Risk in Patients with Ischemic Heart Disease |
Abstract
PDF (Rus)
|
|
L. L. Bershtein |
| |
| Vol 60, No 11 (2020) |
Efficacy and Safety of Combined Treament with Ivabradine and Metoprolol in Patients with Stable Angina Pectoris – a Systematic Review |
Abstract
PDF (Rus)
|
|
s. R. Gilarevskii, E. V. Lantsova, A. A. Akimov |
| |
| Vol 60, No 11 (2020) |
Clinical Manifestation of Stressful Cardiomyopathy (Takotsubo Syndrome) and the Problem of Differential Diagnosis with Acute Myocardial Infarction |
Abstract
PDF (Rus)
|
|
E. S. Prokudina, B. K. Kurbatov, L. N. Maslov |
| |
| Vol 60, No 10 (2020) |
The Choice of Priorities in Contemporary Comparative Trials: Superiority vs non Inferiority. Causes and Effects |
Abstract
PDF (Rus)
|
|
F. T. Ageev, E. B. Yarovaya |
| |
| Vol 60, No 10 (2020) |
Asymptomatic Hyperuricemia and Risk Of Cardiovascular and Renal Diseases |
Abstract
PDF (Rus)
|
|
Zh. D. Kobalava, E. A. Troitskaya |
| |
| Vol 60, No 10 (2020) |
Possibilities of Stress Computed Tomography Myocardial Perfusion Imaging in the Diagnosis of Ischemic Heart Disease |
Abstract
PDF (Rus)
|
|
Y. A. Omarov, T. S. Sukhinina, T. N. Veselova, R. M. Shakhnovich, N. S. Zhukova, I. N. Merkulova, D. V. Pevzner, S. K. Ternovoy, I. I. Staroverov |
| |
| Vol 60, No 10 (2020) |
Comorbidity of arterial hypertension and tension-type headache |
Abstract
PDF (Rus)
|
|
M. M. Petrova, P. V. Moskaleva, N. A. Shnayder, R. F. Nasyrova |
| |
| Vol 60, No 10 (2020) |
Prevention of thromboembolic complications during cardioversion and catheter ablation in patients with atrial fibrillation: review of key randomized trials |
Abstract
PDF (Rus)
|
|
V. A. Ionin |
| |
| Vol 60, No 9 (2020) |
Role of modified cardiovascular risk factors in development of oncologic diseases |
Abstract
PDF (Rus)
|
|
E. Yu. Zvolinskaya, M. N. Mamedov, V. I. Potievskaya, S. A. Ivanov, A. D. Kaprin |
| |
| Vol 60, No 9 (2020) |
Semaglutide for the Management of type 2 Diabetes: Clinical Evidence, Cardioprotective Effects, and Guidelines |
Abstract
PDF (Rus)
|
|
Zh. D. Kobalava, E. V. Kokhan |
| |
| Vol 60, No 9 (2020) |
The place of riociguat in the treatment of patients with pulmonary arterial hypertension associated with systemic connective tissue diseases |
Abstract
PDF (Rus)
|
|
N. A. Shostak, A. A. Klimenko, N. A. Demidova |
| |
| Vol 60, No 9 (2020) |
Comparative efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease |
Abstract
PDF (Rus)
|
|
V. S. Gorbatenko, A. S. Gerasimenko, O. V. Shatalova |
| |
| Vol 60, No 9 (2020) |
Atrial Fibrillation After Coronary Artery Bypass Surgery: Risk Factors, Prevention and Treatment |
Abstract
PDF (Rus)
|
|
E. S. Petrakova, N. M. Savina, A. V. Molochkov |
| |
| Vol 60, No 8 (2020) |
Evidence-Based Information Which Could Influence Arterial Hypertension Treatment Approach after Publication of SPRINT Trial Results |
Abstract
PDF (Rus)
|
|
S. R. Gilyarevsky, N. G. Bendeliani, M. V. Golshmid, G. Yu. Zaharova, I. M. Kuzmina, Irina Ivanovna Sinitcina |
| |
| Vol 60, No 8 (2020) |
Direct Oral Anticoagulant Edoxaban in Patients with Non-Valvular Atrial Fibrillation: Results of Direct Comparison with Warfarin |
Abstract
PDF (Rus)
|
|
I. S. Yavelov |
| |
| Vol 60, No 8 (2020) |
The soluble guanylate cyclase stimulator riociguat is the first-line therapy for chronic thromboembolic pulmonary hypertension patients |
Abstract
PDF (Rus)
|
|
Z. S. Valieva, S. E. Gratsianskaya, T. V. Martynyuk |
| |
| Vol 60, No 7 (2020) |
Combined Lipid-Lowering Therapy in Elderly and Senile Patients |
Abstract
PDF (Rus)
|
|
I. I. Shaposhnik, V. V. Genkel, A. O. Salashenko |
| |
| Vol 60, No 7 (2020) |
Atrial Fibrillation and Diabetes Mellitus: the Control of Thromboembolic Risk |
Abstract
PDF (Rus)
|
|
A. G. Obrezan, N. V. Kulikov |
| |
| Vol 60, No 7 (2020) |
The balance of benefit and risk in prescribing antithrombotic therapy for patients with coronary artery disease. How to deal with the gastrointestinal bleeding problem? |
Abstract
PDF (Rus)
|
|
A. L. Komarov, O. O. Shakhmatova, V. V. Korobkova |
| |
| Vol 60, No 7 (2020) |
Gastrointestinal Bleeding in Patients with Coronary Heart Disease: Preventive Options |
Abstract
PDF (Rus)
|
|
N. S. Lapina, A. A. Alekseeva, A. D. Vershinina, N. S. Khruleva, D. S. Zlobina, L. Yu. Koroleva |
| |
| 1 - 100 of 189 Items |
1 2 > >>
|
